C. Diff clinical trials at UC Davis

1 in progress, 0 open to eligible people

ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Sorry, not currently recruiting here
Single-arm trial to evaluate the safety and efficacy of ACX-362E [ibezapolstat] in patients with recurrent C. difficile infection (CDI).
Sacramento, California and other locations

Last updated: August 10, 2026